BIOMAT Database Logo BIOMAT Database Logo

Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus. 1991

D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Malaria Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

Many candidate antigens of malaria vaccines have limited immunological recognition. One exception is Pfs25, a cysteine-rich, 25-kilodalton sexual stage surface protein of Plasmodium falciparum. Pfs25 is a target of monoclonal antibodies that block transmission of malaria from vertebrate host to mosquito vector. The surface of mammalian cells infected with a recombinant vaccinia virus that expressed Pfs25 specifically bound transmission-blocking monoclonal antibodies. Furthermore, major histocompatibility complex-disparate congenic mouse strains immunized with recombinant Pfs25 elicited transmission-blocking antibodies, demonstrating that the capacity to develop transmission-blocking antibodies is not genetically restricted in mice. Live recombinant viruses may provide an inexpensive, easily administered alternative to subunit vaccines prepared from purified recombinant proteins to block transmission of malaria in developing countries.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000913 Antibodies, Protozoan Immunoglobulins produced in a response to PROTOZOAN ANTIGENS. Protozoan Antibodies
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014616 Vaccinia virus The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS. Buffalopox virus,Poxvirus officinale,Rabbitpox virus,Buffalo Pox Virus,Rabbit Pox Virus,Buffalo Pox Viruses,Buffalopox viruses,Rabbit Pox Viruses,Rabbitpox viruses,Vaccinia viruses,Virus, Buffalo Pox,Viruses, Buffalo Pox,virus, Buffalopox
D015800 Protozoan Proteins Proteins found in any species of protozoan. Proteins, Protozoan

Related Publications

D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Plasmodium falciparum: heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 in recombinant vaccinia virus-infected cells.
October 1998, Experimental parasitology,
D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Extending the range of Plasmodium falciparum transmission blocking antibodies.
May 2023, Vaccine,
D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Induction of Plasmodium falciparum sporozoite-neutralizing antibodies upon vaccination with recombinant Pfs16 vaccinia virus and/or recombinant Pfs16 protein produced in yeast.
June 1995, Molecular and biochemical parasitology,
D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Plasmodium falciparum transmission blocking monoclonal antibodies recognize monovalently expressed epitopes.
January 1985, Developments in biological standardization,
D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.
January 2004, Infection and immunity,
D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Biosynthesis of the target antigens of antibodies blocking transmission of Plasmodium falciparum.
November 1984, Molecular and biochemical parasitology,
D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Effects of transmission-blocking monoclonal antibodies on different isolates of Plasmodium falciparum.
June 1985, Infection and immunity,
D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.
November 1991, The Journal of experimental medicine,
D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Mapping of two overlapping linear epitopes in Pfg27 recognized by Plasmodium falciparum transmission-blocking monoclonal antibodies.
September 1995, Vaccine,
D C Kaslow, and S N Isaacs, and I A Quakyi, and R W Gwadz, and B Moss, and D B Keister
Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus.
March 1993, The Journal of general virology,
Copied contents to your clipboard!